MedTrace Logo

Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

NCT00498082 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2007-09-06

No results posted yet for this study

Summary

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.

The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Hubert Piessevaux, MD, PhD · Cliniques universitaires St-Luc

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Completion
2008-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00498082 on ClinicalTrials.gov